<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endoscopic surveillance is recommended for patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to detect high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the outcome of esophagectomy in a cohort of patients who developed HGD or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> between 1995 and 2003 while under surveillance for Barrett's </plain></SENT>
<SENT sid="2" pm="."><plain>Outcomes were measured by analysis of clinical records, symptom questionnaire, and SF-36 (version 2) </plain></SENT>
<SENT sid="3" pm="."><plain>In 34 patients, mean surveillance time was 48 months (range, 4-132); the mean number of endoscopies was 10 (range, 3-30) </plain></SENT>
<SENT sid="4" pm="."><plain>Preoperative diagnosis was HGD in 9 patients (26.5%), <z:mp ids='MP_0002038'>carcinoma</z:mp> in situ in 16 (47%), and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in 9 (26.5%) </plain></SENT>
<SENT sid="5" pm="."><plain>There was no esophagectomy-related mortality; 10 patients (29%) had complications </plain></SENT>
<SENT sid="6" pm="."><plain>At mean follow-up of 46 months (range, 13-108), SF-36 (version 2) results showed quality of life scores equal to or better than those of healthy individuals </plain></SENT>
<SENT sid="7" pm="."><plain>Incidence and severity scores (VAS 1-10) for postoperative symptoms were reflux, 59% (2.8); <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, 28% (3.7); <z:mp ids='MP_0009247'>bloating</z:mp>, 45% (2.6); <z:hpo ids='HP_0002018'>nausea</z:hpo>, 28% (2.1); and <z:hpo ids='HP_0002014'>diarrhea</z:hpo>, 55% (2.5) </plain></SENT>
<SENT sid="8" pm="."><plain>Twenty-nine patients (85%) have no clinical, radiographic, or endoscopic evidence of <z:e sem="disease" ids="C0854761" disease_type="Neoplastic Process" abbrv="">recurrent esophageal cancer</z:e> or <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>One patient has <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Endoscopic surveillance in Barrett's patients yields malignant lesions at an early, generally curable, stage </plain></SENT>
<SENT sid="11" pm="."><plain>Esophagectomy is curative in the great majority and can be accomplished with minimal mortality and excellent quality of life </plain></SENT>
</text></document>